Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (181-190 of 498) with videos related to

Pageof 50
Sort By:
Oral Oncology|July 22, 2014
The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scanPaul B Romesser, Remy Lim, Daniel E Spratt, et al.
Clinical Nuclear Medicine|May 21, 2019
Thyroid Cancer Brain Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care CohortJoseph R Osborne, Jessica D Kondraciuk, Samuel L Rice, et al.
BJU International|May 3, 2017
Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancerZachary S Zumsteg, Michael J Zelefsky, Kaitlin M Woo, et al.
Medical Physics|February 24, 2018
Changes in prostate orientation due to removal of a Foley catheterDale W Litzenberg, Daniel G Muenz, Paul G Archer, et al.
Molecular Imaging and Biology|July 12, 2017
Erratum to: Repeatability of [<sup>68</sup>Ga]DKFZ11-PSMA PET Scans for Detecting Prostate-specific Membrane Antigen-positive Prostate CancerJoseph R Osborne, Teja M Kalidindi, Blesida J Punzalan, et al.
The Prostate|May 26, 2026
Characterizing the Activity of Inflammasome-Related Genes and Their Association With Oncological Outcomes in Prostate CancerAlireza Ghoreifi, Mohammed Alshalalfa, Elai Davicioni, et al.
American Journal of Clinical Oncology|April 11, 2023
Unknown Causes of Death in Cancer PatientsSiven Chinniah, Mckenzee Chiam, Kyle Mani, et al.
Practical Radiation Oncology|June 18, 2022
Lutetium-177 DOTATATE: A Practical ReviewAngela Y Jia, Rojano Kashani, Nicholas G Zaorsky, et al.
European Urology|January 27, 2019
Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason ScoresBrandon A Mahal, Mohammed Alshalalfa, Daniel E Spratt, et al.
The Prostate|September 20, 2017
Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Heather H Cheng, Wassim Abida, et al.
Pageof 50

Showing results (181-190 of 498) with videos related to

Sort By:
Pageof 50
Oral Oncology|July 22, 2014
The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scanPaul B Romesser, Remy Lim, Daniel E Spratt, et al.
Clinical Nuclear Medicine|May 21, 2019
Thyroid Cancer Brain Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care CohortJoseph R Osborne, Jessica D Kondraciuk, Samuel L Rice, et al.
BJU International|May 3, 2017
Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancerZachary S Zumsteg, Michael J Zelefsky, Kaitlin M Woo, et al.
Medical Physics|February 24, 2018
Changes in prostate orientation due to removal of a Foley catheterDale W Litzenberg, Daniel G Muenz, Paul G Archer, et al.
Molecular Imaging and Biology|July 12, 2017
Erratum to: Repeatability of [<sup>68</sup>Ga]DKFZ11-PSMA PET Scans for Detecting Prostate-specific Membrane Antigen-positive Prostate CancerJoseph R Osborne, Teja M Kalidindi, Blesida J Punzalan, et al.
The Prostate|May 26, 2026
Characterizing the Activity of Inflammasome-Related Genes and Their Association With Oncological Outcomes in Prostate CancerAlireza Ghoreifi, Mohammed Alshalalfa, Elai Davicioni, et al.
American Journal of Clinical Oncology|April 11, 2023
Unknown Causes of Death in Cancer PatientsSiven Chinniah, Mckenzee Chiam, Kyle Mani, et al.
Practical Radiation Oncology|June 18, 2022
Lutetium-177 DOTATATE: A Practical ReviewAngela Y Jia, Rojano Kashani, Nicholas G Zaorsky, et al.
European Urology|January 27, 2019
Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason ScoresBrandon A Mahal, Mohammed Alshalalfa, Daniel E Spratt, et al.
The Prostate|September 20, 2017
Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Heather H Cheng, Wassim Abida, et al.
Pageof 50